HOME >> BIOLOGY >> NEWS
Fungus helps tall fescue choke out native plants

HOUSTON, Aug. 29, 2005 New research by biologists at Rice University, Indiana University and George Mason University reveals how some non-native fescue grass gets a leg up over competing native plants: it's passed over by plant-eating insects and animals because its leaves are laced with toxic alkaloids, thanks to a symbiotic fungus that has co-evolved with the grass.

In a 54-month study conducted at Indiana University, scientists showed that 'tall fescue,' a common variety that is infected with the symbiotic fungus Neotyphodium coenophialum, tended to choke out uninfected fescue and native plant species. Tall fescue took over test plots much more quickly when herbivores had full access.

The research appears in the Aug. 30 issue of the Proceedings of the National Academy of Science.

"The practical implications of our findings are that the more herbivores there are in an area, the more likely it will be that infected tall fescue grass will spread and suppress native plants," said co-author Jennifer Rudgers, now an assistant professor of ecology and evolutionary biology at Rice.

Fescue, which is native to the Mediterranean, covers an estimated 37 million U.S. acres. It is cultivated for grazing and is often used as turf grass on lawns, golf courses and highway rights-of-way. Ranchers do not typically cultivate tall fescue because the symbiotic fungus it carries, known as an endophyte, produces alkaloids that have negative health effects for livestock. It is estimated that 80 percent of U.S. fescue is endophyte-infected, and in some applications, like turf grass, it's the preferred variety.

Prior research on hereditary plant symbionts like the fescue endophyte have tended to look at plant-fungal pairings in isolation. Rudgers said she, post-doc advisor Keith Clay of Indiana University, and co-author Jenny Holah of George Mason University sought to get a more realistic picture of the ecological effects of symbiosis. <
'"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
29-Aug-2005


Page: 1 2

Related biology news :

1. Fungus-farming termites descend from an African rain forest Eve
2. Fungus-friendly scientists meet in Tucson
3. Fungus knocks a frog down but not out, raising questions about amphibian declines
4. Genetic variation helps to understand predisposition to schizophrenia
5. Link between sunspots, rain helps predict disease in east Africa
6. Taking a supplement of glycine helps prevent degenerative diseases such as arthrosis or osteoporosis
7. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
8. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
9. Preconditioning helps protect brains blood vessels from stroke
10. Manchester University helps with pharaoh DNA analysis
11. A spoonful of sugar helps your waistline go down

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Fungus helps tall fescue choke out native plants

(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/10/2014)... 2014  Wake Forest Baptist Medical Center today announced plans ... of Medicine. Funding for this $50 million capital project ... be publicly launched next summer. The ... 60 series R.J. Reynolds Tobacco Company complex, adjacent to ... immediately with plans to be ready to welcome medical ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/15/2014)... Dec. 15, 2014  Ascendis Pharma A/S, a ... to address significant unmet medical needs, today announced ... 2 pediatric study to evaluate once-weekly TransCon Growth ... GHD.  This interim analysis consists of 25 patients, ... in the study, completing all six months of ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 The ... million in 2013, and is expected to grow ... 2019. , Browse through the TOC of the ... industry trends and segments, with help of various ... The global DNA Microarray market consists of instrument, ...
(Date:12/13/2014)... 2014 QuickSTAT is making significant investments ... Chain capabilities, and is delighted to announce the opening ... serve Life Science clients in the region. , QuickSTAT ... warehouse, will provide 24/7 transportation and logistics services, as ... patient-clinical specimens, API, following IATA rules and EU GDP ...
(Date:12/13/2014)... ANTONIO , Dec. 12, 2014  Janssen Research ... data at the San Antonio Breast Cancer Symposium (SABCS) ... plus best supportive care (BSC) versus BSC when used ... receiving standard chemotherapy. This non-inferiority trial did not meet ... 15 percent or greater increase in the risk of ...
Breaking Biology Technology:Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 2DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 3DNA Microarray Market Is Expected to Grow at a CAGR of 15.2% from 2014 to 2019 - A Report by MicroMarket Monitor 4Quick Opens Office in France to Serve Life Science Community In France and Neighboring French-Speaking Countries 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 2Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 3Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 4Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 5Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 6Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 7Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 8Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 9Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 10Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 11Data from the EPO-ANE-3010 Study Evaluating Epoetin Alfa Presented at San Antonio Breast Cancer Symposium 12
Cached News: